1.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: VION-CLI-037, NCT00112554
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: VION-CLI-041, MDA-2005-0249, NCT00304005
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: VION-CLI-033, NCT00083187
|
|
4.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: VION-CLI-039, NCT00282022
|
|
5.
|
Phase: Phase II Type: Treatment Status: Closed Age: 60 and over Sponsor: Pharmaceutical / Industry Protocol IDs: VION-CLI-043, NCT00354276, EUDRACT-2006-001853-89
|
|
6.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: VION-CLI-011, NCI-V01-1669, NCT00025129
|
|
7.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: VION-CLI-029, MDA-DM-02202, NCT00049686
|
|
8.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: VION-CLI-028, YALE-HIC-16775, NCT00049699
|
|
9.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: VION-CLI-034, MDA-2003-0326, NCT00070538
|
|
10.
|
Phase: Phase I Type: Treatment Status: Completed Age: 21 and under Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: PBTC-017, VION-VNP40101M, NCT00098761
|
|
11.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: VION-CLI-036, CWRU-050419, NCT00098436
|
|
12.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 to 65 Sponsor: Other Protocol IDs: 2005-0844, NCT00521859
|